Cormorant Asset Management, LP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$95
-99.9%
256,6490.0%0.01%
-33.3%
Q3 2022$128,000
-14.7%
256,6490.0%0.01%
-18.2%
Q2 2022$150,000
-18.0%
256,6490.0%0.01%
-21.4%
Q1 2022$183,000
-46.0%
256,6490.0%0.01%
-30.0%
Q4 2021$339,000
-42.5%
256,6490.0%0.02%
-16.7%
Q3 2021$590,000
-47.6%
256,6490.0%0.02%
-36.8%
Q2 2021$1,127,000
-39.5%
256,6490.0%0.04%
-9.5%
Q1 2021$1,863,000
+68.0%
256,6490.0%0.04%
+61.5%
Q4 2020$1,109,000
+5.1%
256,6490.0%0.03%
-36.6%
Q3 2020$1,055,000
-31.5%
256,6490.0%0.04%
-30.5%
Q2 2020$1,540,000
-20.3%
256,6490.0%0.06%
-34.4%
Q1 2020$1,933,000
-59.9%
256,649
-26.7%
0.09%
-53.1%
Q4 2019$4,815,000
-40.0%
350,203
-48.1%
0.19%
-60.7%
Q3 2019$8,023,000
-21.5%
675,325
-7.5%
0.49%
-16.9%
Q2 2019$10,217,000
-12.1%
730,325
+12.3%
0.59%
-25.3%
Q1 2019$11,628,000
+97.1%
650,143
+73.4%
0.79%
+64.1%
Q4 2018$5,899,000375,0000.48%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 2,931,185$12,047,0004.29%
RA Capital Management 12,315,213$50,616,0000.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$28,562,0000.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 620,233$2,549,0000.35%
Casdin Capital, LLC 1,870,000$7,686,0000.34%
Vivo Capital, LLC 1,325,736$5,449,0000.32%
Bleichroeder LP 250,000$1,028,0000.18%
Virtus ETF Advisers LLC 40,292$166,0000.09%
Forefront Analytics, LLC 30,369$123,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 411,977$1,693,0000.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders